Literature DB >> 1575005

Malformations in offspring of 305 epileptic women: a prospective study.

D Battino1, S Binelli, M L Caccamo, M P Canevini, R Canger, M L Como, D Croci, M De Giambattista, T Granata, G Pardi.   

Abstract

This paper deals with malformations detected in 26 of 315 newborns of 305 epileptic mothers followed prospectively. In 3 more cases, malformations were detected in utero and therapeutic abortion was performed. Two hundred and seven women were on monotherapy, 102 on polytherapy and 9 were not treated. In total, malformations overall incidence was 9.1%. Minor anomalies were detected in 42 newborns (13.3%). A higher rate of malformations and minor anomalies was found among offspring of mothers treated with valproic acid (VPA). In the VPA group, mothers of malformed babies had higher plasma levels in the first trimester than mothers of babies without malformations. The need for accurate prenatal diagnostic studies in pregnant women with epilepsy is stressed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1575005     DOI: 10.1111/j.1600-0404.1992.tb04029.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  11 in total

1.  Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy.

Authors:  A Ornoy; E Cohen
Journal:  Arch Dis Child       Date:  1996-12       Impact factor: 3.791

Review 2.  Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child.

Authors:  Jennifer Weston; Rebecca Bromley; Cerian F Jackson; Naghme Adab; Jill Clayton-Smith; Janette Greenhalgh; Juliet Hounsome; Andrew J McKay; Catrin Tudur Smith; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2016-11-07

3.  Additional educational needs in children born to mothers with epilepsy.

Authors:  N Adab; A Jacoby; D Smith; D Chadwick
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-01       Impact factor: 10.154

Review 4.  Treating recurrent affective disorders during and after pregnancy. What can be taken safely?

Authors:  M Schou
Journal:  Drug Saf       Date:  1998-02       Impact factor: 5.606

5.  A clinical study of 57 children with fetal anticonvulsant syndromes.

Authors:  S J Moore; P Turnpenny; A Quinn; S Glover; D J Lloyd; T Montgomery; J C Dean
Journal:  J Med Genet       Date:  2000-07       Impact factor: 6.318

6.  Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth.

Authors:  J C S Dean; H Hailey; S J Moore; D J Lloyd; P D Turnpenny; J Little
Journal:  J Med Genet       Date:  2002-04       Impact factor: 6.318

7.  The longer term outcome of children born to mothers with epilepsy.

Authors:  N Adab; U Kini; J Vinten; J Ayres; G Baker; J Clayton-Smith; H Coyle; A Fryer; J Gorry; J Gregg; G Mawer; P Nicolaides; L Pickering; L Tunnicliffe; D W Chadwick
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-11       Impact factor: 10.154

Review 8.  Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts.

Authors:  Kimford Meador; Matthew W Reynolds; Sheila Crean; Kyle Fahrbach; Corey Probst
Journal:  Epilepsy Res       Date:  2008-06-18       Impact factor: 3.045

9.  Effect of anti-epileptic drugs in pregnancy and teratogenesis.

Authors:  Sowbhagya Lakshmi; Kulkarni Sunanda
Journal:  Indian J Clin Biochem       Date:  2008-10-01

10.  Teratogenicity of Antiepileptic Drugs.

Authors:  Betül Tekin Güveli; Rasim Özgür Rosti; Alper Güzeltaş; Elif Bahar Tuna; Dilek Ataklı; Serra Sencer; Ensar Yekeler; Hülya Kayserili; Ahmet Dirican; Nerses Bebek; Betül Baykan; Ayşen Gökyiğit; Candan Gürses
Journal:  Clin Psychopharmacol Neurosci       Date:  2017-02-28       Impact factor: 2.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.